BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14671641)

  • 1. Simultaneous detection of the immunophenotypic markers and genetic aberrations on routinely processed paraffin sections of lymphoma samples by means of the FICTION technique.
    Martínez-Ramírez A; Cigudosa JC; Maestre L; Rodríguez-Perales S; Haralambieva E; Benítez J; Roncador G
    Leukemia; 2004 Feb; 18(2):348-53. PubMed ID: 14671641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous phenotyping and genotyping (FICTION-methodology) on paraffin sections and cytologic specimens: a comparison of 2 different protocols.
    Bzorek M; Petersen BL; Hansen L
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):279-86. PubMed ID: 18301240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FISH and FICTION to detect chromosomal aberrations in lymphomas.
    Giefing M; Siebert R
    Methods Mol Biol; 2013; 971():227-44. PubMed ID: 23296967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.
    Martín-Subero JI; Chudoba I; Harder L; Gesk S; Grote W; Novo FJ; Calasanz MJ; Siebert R
    Am J Pathol; 2002 Aug; 161(2):413-20. PubMed ID: 12163366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the FICTION technique for the simultaneous detection of immunophenotype and chromosomal abnormalities in routinely fixed, paraffin wax embedded bone marrow trephines.
    Korac P; Jones M; Dominis M; Kusec R; Mason DY; Banham AH; Ventura RA
    J Clin Pathol; 2005 Dec; 58(12):1336-8. PubMed ID: 16311361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FISH and FICTION in Lymphoma Research.
    Giefing M; Siebert R
    Methods Mol Biol; 2019; 1956():249-267. PubMed ID: 30779038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of FICTION technique to the detection of genetic aberrations in multiple myeloma].
    Wang D; Huang L; Zhang H; Geng Z; Shang Z; Zhou JF; Li CR
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):226-30. PubMed ID: 21569703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid immunophenotypic characterization of chromosomally aberrant cells by the new FICTION method.
    Weber-Matthiesen K; Deerberg J; Müller-Hermelink A; Schlegelberger B; Grote W
    Cytogenet Cell Genet; 1993; 63(2):123-5. PubMed ID: 8385597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method.
    Weber-Matthiesen K; Pressl S; Schlegelberger B; Grote W
    Leukemia; 1993 Apr; 7(4):646-9. PubMed ID: 8464243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma.
    Sargent RL; Cook JR; Aguilera NI; Surti U; Abbondanzo SL; Gollin SM; Swerdlow SH
    Am J Surg Pathol; 2008 Nov; 32(11):1643-53. PubMed ID: 18670352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections.
    Haralambieva E; Kleiverda K; Mason DY; Schuuring E; Kluin PM
    J Pathol; 2002 Oct; 198(2):163-70. PubMed ID: 12237875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions.
    Mühlmann M
    Genet Mol Res; 2002 Jun; 1(2):117-27. PubMed ID: 14963837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of interphase fluorescence in situ hybridization for detection of chromosome aberrations in tumor pathology.
    Tibiletti MG
    Cancer Genet Cytogenet; 2004 Dec; 155(2):143-8. PubMed ID: 15571800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination of distinct subpopulations within a tumor with combined double immunophenotyping and interphase cytogenetics.
    Weber-Matthiesen K; Müller-Hermelink A; Deerberg J; Scherthan H; Schlegelberger B; Grote W
    J Histochem Cytochem; 1993 Nov; 41(11):1641-4. PubMed ID: 7691932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Culture System and Combination of FICTION Could Increase the Detection Rate of Abnormalities in Multiple Myeloma.
    Fu Q; Xie S; Chen J; Huang H
    Ann Clin Lab Sci; 2021 Jan; 51(1):61-72. PubMed ID: 33653782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence-intensity multiplexing: simultaneous seven-marker, two-color immunophenotyping using flow cytometry.
    Bradford JA; Buller G; Suter M; Ignatius M; Beechem JM
    Cytometry A; 2004 Oct; 61(2):142-52. PubMed ID: 15382027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization for cancer-related studies.
    Kearney L; Shipley J
    Methods Mol Biol; 2012; 878():149-74. PubMed ID: 22674132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.
    Martín-Subero JI; Gesk S; Harder L; Grote W; Siebert R
    Anticancer Res; 2003; 23(2A):1139-48. PubMed ID: 12820362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.